Logo image of AIXI

XIAO I CORP (AIXI) Stock Fundamental Analysis

NASDAQ:AIXI - Nasdaq - US98423X2099 - ADR - Currency: USD

4.5  -0.21 (-4.46%)

After market: 4.7377 +0.24 (+5.28%)

Fundamental Rating

2

Overall AIXI gets a fundamental rating of 2 out of 10. We evaluated AIXI against 284 industry peers in the Software industry. Both the profitability and financial health of AIXI have multiple concerns. AIXI is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AIXI had negative earnings in the past year.
AIXI Yearly Net Income VS EBIT VS OCF VS FCFAIXI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -10M -20M

1.2 Ratios

The Return On Assets of AIXI (-47.92%) is worse than 85.20% of its industry peers.
Industry RankSector Rank
ROA -47.92%
ROE N/A
ROIC N/A
ROA(3y)-13.94%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AIXI Yearly ROA, ROE, ROICAIXI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 500 -500 -1K -1.5K

1.3 Margins

AIXI has a Gross Margin (65.88%) which is in line with its industry peers.
AIXI's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for AIXI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 65.88%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.68%
GM growth 5YN/A
AIXI Yearly Profit, Operating, Gross MarginsAIXI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

1

2. Health

2.1 Basic Checks

AIXI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AIXI remains at a similar level compared to 1 year ago.
Compared to 1 year ago, AIXI has an improved debt to assets ratio.
AIXI Yearly Shares OutstandingAIXI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M 8M 10M
AIXI Yearly Total Debt VS Total AssetsAIXI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

AIXI has an Altman-Z score of -2.55. This is a bad value and indicates that AIXI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AIXI (-2.55) is worse than 79.06% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.55
ROIC/WACCN/A
WACC11.28%
AIXI Yearly LT Debt VS Equity VS FCFAIXI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 -5M -10M -15M

2.3 Liquidity

A Current Ratio of 0.64 indicates that AIXI may have some problems paying its short term obligations.
AIXI has a worse Current ratio (0.64) than 89.17% of its industry peers.
AIXI has a Quick Ratio of 0.64. This is a bad value and indicates that AIXI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of AIXI (0.64) is worse than 88.45% of its industry peers.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.64
AIXI Yearly Current Assets VS Current LiabilitesAIXI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 41.38% over the past year.
The Revenue has grown by 23.38% in the past year. This is a very strong growth!
Measured over the past years, AIXI shows a very strong growth in Revenue. The Revenue has been growing by 62.23% on average per year.
EPS 1Y (TTM)41.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.21%
Revenue 1Y (TTM)23.38%
Revenue growth 3Y62.23%
Revenue growth 5YN/A
Sales Q2Q%24.47%

3.2 Future

The Earnings Per Share is expected to grow by 33.57% on average over the next years. This is a very strong growth
Based on estimates for the next years, AIXI will show a very strong growth in Revenue. The Revenue will grow by 22.78% on average per year.
EPS Next Y36.45%
EPS Next 2Y33.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.85%
Revenue Next 2Y22.78%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
AIXI Yearly Revenue VS EstimatesAIXI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
AIXI Yearly EPS VS EstimatesAIXI Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AIXI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AIXI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AIXI Price Earnings VS Forward Price EarningsAIXI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AIXI Per share dataAIXI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

A more expensive valuation may be justified as AIXI's earnings are expected to grow with 33.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.57%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AIXI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

XIAO I CORP

NASDAQ:AIXI (2/5/2025, 8:00:00 PM)

After market: 4.7377 +0.24 (+5.28%)

4.5

-0.21 (-4.46%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)10-15 2024-10-15
Earnings (Next)N/A N/A
Inst Owners0.08%
Inst Owner Change-0.21%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap47.46M
AnalystsN/A
Price Target18.36 (308%)
Short Float %1.91%
Short Ratio1.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.52
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.02
EYN/A
EPS(NY)-0.55
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.73
BVpS-1.85
TBVpS-1.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -47.92%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 65.88%
FCFM N/A
ROA(3y)-13.94%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.68%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.64
Altman-Z -2.55
F-ScoreN/A
WACC11.28%
ROIC/WACCN/A
Cap/Depr(3y)129.35%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.34%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.21%
EPS Next Y36.45%
EPS Next 2Y33.57%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.38%
Revenue growth 3Y62.23%
Revenue growth 5YN/A
Sales Q2Q%24.47%
Revenue Next Year22.85%
Revenue Next 2Y22.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-119.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-63.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.55%
OCF growth 3YN/A
OCF growth 5YN/A